Adding Artificial Intelligence (AI) System to Breast Ultrasound Can Reduce Unnecessary Biopsies, Finds Study
|
By HospiMedica International staff writers Posted on 11 Mar 2021 |
|
Illustration
A new study has determined that artificial intelligence (AI) can be an adjunct tool for breast ultrasound to reduce excessive lesion biopsy.
Researchers at Peking University Third Hospital (Beijing, China) conducted a study to determine whether adding an AI system to breast ultrasound can reduce unnecessary biopsies. In the study, conventional ultrasound and AI analyses were prospectively performed on 173 suspicious breast lesions before ultrasound-guided core needle biopsy or vacuum-assisted excision. Conventional ultrasound images were retrospectively reviewed according to the BI-RADS 2013 lexicon and categories. Two downgrading stratifications based on AI assessments were manually used to downgrade the BI-RADS category 4A lesions to category 3. Stratification A was used to downgrade if the assessments of both orthogonal sections of a lesion from AI were possibly benign. Stratification B was used to downgrade if the assessment of any of the orthogonal sections was possibly benign. The effects of AI-based diagnosis on lesions to reduce unnecessary biopsy were analyzed using histopathological results as reference standards.
The researchers found that 43 lesions diagnosed as BI-RADS category 4A by conventional ultrasound received AI-based hypothetical downgrading. While downgrading with stratification A, 14 biopsies were correctly avoided. The biopsy rate for BI-RADS category 4A lesions decreased from 100% to 67.4% (P < 0.001). While downgrading with stratification B, 27 biopsies could be avoided with two malignancies missed, and the biopsy rate decreased to 37.2% (P < 0.05, compared with conventional ultrasound and stratification A). Based on their findings, the researchers concluded that adding an AI system to breast ultrasound could reduce unnecessary lesion biopsies and have recommended downgrading stratification A for its lower misdiagnosis rate.
Related Links:
Peking University Third Hospital
Researchers at Peking University Third Hospital (Beijing, China) conducted a study to determine whether adding an AI system to breast ultrasound can reduce unnecessary biopsies. In the study, conventional ultrasound and AI analyses were prospectively performed on 173 suspicious breast lesions before ultrasound-guided core needle biopsy or vacuum-assisted excision. Conventional ultrasound images were retrospectively reviewed according to the BI-RADS 2013 lexicon and categories. Two downgrading stratifications based on AI assessments were manually used to downgrade the BI-RADS category 4A lesions to category 3. Stratification A was used to downgrade if the assessments of both orthogonal sections of a lesion from AI were possibly benign. Stratification B was used to downgrade if the assessment of any of the orthogonal sections was possibly benign. The effects of AI-based diagnosis on lesions to reduce unnecessary biopsy were analyzed using histopathological results as reference standards.
The researchers found that 43 lesions diagnosed as BI-RADS category 4A by conventional ultrasound received AI-based hypothetical downgrading. While downgrading with stratification A, 14 biopsies were correctly avoided. The biopsy rate for BI-RADS category 4A lesions decreased from 100% to 67.4% (P < 0.001). While downgrading with stratification B, 27 biopsies could be avoided with two malignancies missed, and the biopsy rate decreased to 37.2% (P < 0.05, compared with conventional ultrasound and stratification A). Based on their findings, the researchers concluded that adding an AI system to breast ultrasound could reduce unnecessary lesion biopsies and have recommended downgrading stratification A for its lower misdiagnosis rate.
Related Links:
Peking University Third Hospital
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Desk Aneroid Sphyg
Diagnostix 750D+
New
Wound Irrigation Solution
Prontosan®
Latest AI News
- Machine Learning Approach Enhances Liver Cancer Risk Stratification
- New AI Approach Monitors Brain Health Using Passive Wearable Data
- AI Tool Maps Early Risk Patterns in Bloodstream Infections
- AI Model Identifies Rare Endocrine Disorder from Hand Images
- AI Tool Promises to Reduce Length of Hospital Stays and Free Up Beds
- Machine Learning Model Cuts Canceled Liver Transplants By 60%
Channels
Critical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read more
Surgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
